Myokardia, Inc. (MYOK)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
19-Nov-20 8:21 PM
View: 
Harris Taylor C.
Chief Financial Officer
Myokardia, Inc. (MYOK) 17-Nov-20Disposition (change in control) 42,559----(100%)
42.56K to 0
19-Nov-20 8:13 PM
View: 
Waynick Denelle J
Chief Legal Officer
Myokardia, Inc. (MYOK) 17-Nov-20Disposition (change in control) 25,000----(100%)
25.0K to 0
19-Nov-20 8:26 PM
View: 
Meeker David P
Director
Myokardia, Inc. (MYOK) 17-Nov-20Disposition (change in control) 4,100----(100%)
4.1K to 0
19-Nov-20 8:20 PM
View: 
Agarwal Sunil
Director
Myokardia, Inc. (MYOK) 17-Nov-20Disposition (change in control) 4,100----(100%)
4.1K to 0
19-Nov-20 8:19 PM
View: 
Perry Mark L
Director
Myokardia, Inc. (MYOK) 17-Nov-20Disposition (change in control) 29,508----(100%)
29.51K to 0
19-Nov-20 8:16 PM
View: 
Cranston Mary B
Director
Myokardia, Inc. (MYOK) 17-Nov-20Disposition (change in control) 4,100----(100%)
4.1K to 0
19-Nov-20 8:15 PM
View: 
Gianakakos Anastasios
President and CEO
Director
Myokardia, Inc. (MYOK) 17-Nov-20Disposition (change in control) 141,405----(19%)
747.07K to 605.67K
19-Nov-20 8:20 PM
View: 
Fairey William
EVP, Chief Commercial Officer
Myokardia, Inc. (MYOK) 17-Nov-20Disposition (change in control) 42,199----(100%)
42.2K to 0
19-Nov-20 8:16 PM
View: 
Popovits Kimberly J
Director
Myokardia, Inc. (MYOK) 17-Nov-20Disposition (change in control) 4,100----(100%)
4.1K to 0
19-Nov-20 8:26 PM
View: 
McDowell Robert Scott
Chief Scientific Officer
Myokardia, Inc. (MYOK) 17-Nov-20Disposition (change in control) 36,616----(100%)
36.62K to 0
19-Nov-20 8:19 PM
View: 
Bauer Jake
Chief Business Officer
Myokardia, Inc. (MYOK) 17-Nov-20Disposition (change in control) 90,209----(100%)
90.21K to 0
19-Nov-20 8:15 PM
View: 
Gianakakos Anastasios
President and CEO
Director
Myokardia, Inc. (MYOK) 17-Nov-20Disposition (change in control) 605,668----(100%)
605.67K to 0
19-Nov-20 8:15 PM
View: 
Yarno Wendy L
Director
Myokardia, Inc. (MYOK) 17-Nov-20Disposition (change in control) 5,508----(100%)
5.51K to 0
07-Jul-20 5:39 PM
View: 
Gianakakos Anastasios
President and CEO
Director
Myokardia, Inc. (MYOK) 02-Jul-20Private Sale (Planned) 5,000$93.98$469,909.00(< 1%)
629.79K to 624.79K
01-Jul-20 7:28 PM
View: 
Cranston Mary B
Director
Myokardia, Inc. (MYOK) 30-Jun-20Private Option Sale 21,629$96.60$2,089,360.00(100%)
21.63K to 0
01-Jul-20 7:28 PM
View: 
Cranston Mary B
Director
Myokardia, Inc. (MYOK) 30-Jun-20Option Exercise 21,629$11.69$252,843.00100%
0 to 21.63K
01-Jul-20 7:28 PM
View: 
Cranston Mary B
Director
Myokardia, Inc. (MYOK) 29-Jun-20Option Exercise 371$11.69$4,336.99100%
0 to 0.37K
01-Jul-20 7:28 PM
View: 
Cranston Mary B
Director
Myokardia, Inc. (MYOK) 29-Jun-20Private Option Sale 371$98.68$36,611.10(100%)
0.37K to 0
16-Jun-20 6:09 PM
View: 
Agarwal Sunil
Director
Myokardia, Inc. (MYOK) 13-Jun-20Option Exercise 2,300----100%
0 to 2.3K
16-Jun-20 6:02 PM
View: 
Yarno Wendy L
Director
Myokardia, Inc. (MYOK) 13-Jun-20Option Exercise 2,300----163%
1.41K to 3.71K
16-Jun-20 6:07 PM
View: 
Popovits Kimberly J
Director
Myokardia, Inc. (MYOK) 13-Jun-20Option Exercise 2,300----100%
0 to 2.3K
16-Jun-20 6:00 PM
View: 
Cranston Mary B
Director
Myokardia, Inc. (MYOK) 13-Jun-20Option Exercise 2,300----100%
0 to 2.3K
16-Jun-20 6:03 PM
View: 
Perry Mark L
Director
Myokardia, Inc. (MYOK) 13-Jun-20Option Exercise 2,300----9%
25.41K to 27.71K
16-Jun-20 6:06 PM
View: 
Meeker David P
Director
Myokardia, Inc. (MYOK) 13-Jun-20Option Exercise 2,300----100%
0 to 2.3K
04-Jun-20 4:24 PM
View: 
Gianakakos Anastasios
President and CEO
Director
Myokardia, Inc. (MYOK) 02-Jun-20Private Sale (Planned) 5,000$102.84$514,208.00(< 1%)
634.79K to 629.79K
20-May-20 4:55 PM
View: 
Gianakakos Anastasios
President and CEO
Director
Myokardia, Inc. (MYOK) 18-May-20Private Sale (Planned) 10,000$125.00$1,250,000.00(2%)
644.79K to 634.79K
13-May-20 5:15 PM
View: 
Gianakakos Anastasios
President and CEO
Director
Myokardia, Inc. (MYOK) 11-May-20Private Sale (Planned) 25,000$101.86$2,546,480.00(4%)
669.79K to 644.79K
06-May-20 7:07 PM
View: 
Gianakakos Anastasios
President and CEO
Director
Myokardia, Inc. (MYOK) 04-May-20Private Sale (Planned) 5,000$58.48$292,388.00(< 1%)
674.79K to 669.79K
04-May-20 5:34 PM
View: 
Gianakakos Anastasios
President and CEO
Director
Myokardia, Inc. (MYOK) 30-Apr-20Grant 421$50.41$21,224.10< 1%
662.87K to 663.29K
(6%)
04-May-20 5:34 PM
View: 
Gianakakos Anastasios
President and CEO
Director
Myokardia, Inc. (MYOK) 30-Apr-20Option Exercise 11,500$1.51$17,328.202%
663.29K to 674.79K
04-Jun-20 4:20 PM
View: 
Bauer Jake
Chief Business Officer
Myokardia, Inc. (MYOK) 30-Apr-20Grant 293$50.41$14,771.20< 1%
57.49K to 57.78K
(6%)
20-Apr-20 6:10 PM
View: 
Gianakakos Anastasios
President and CEO
Director
Myokardia, Inc. (MYOK) 20-Apr-20Gift 122,661----(16%)
785.53K to 662.87K
20-Apr-20 6:10 PM
View: 
Gianakakos Anastasios
President and CEO
Director
Myokardia, Inc. (MYOK) 17-Apr-20Gift 200,865----26%
785.53K to 986.39K
20-Apr-20 6:10 PM
View: 
Gianakakos Anastasios
President and CEO
Director
Myokardia, Inc. (MYOK) 17-Apr-20Gift 200,865----(20%)
986.39K to 785.53K
20-Apr-20 6:10 PM
View: 
Gianakakos Anastasios
President and CEO
Director
Myokardia, Inc. (MYOK) 16-Apr-20Private Sale (Planned) 1,000$55.00$55,000.00(< 1%)
786.53K to 785.53K
10-Apr-20 6:27 PM
View: 
Gianakakos Anastasios
President and CEO
Director
Myokardia, Inc. (MYOK) 08-Apr-20Private Sale (Planned) 1,500$50.00$75,000.00(< 1%)
665.37K to 663.87K
07-Apr-20 5:42 PM
View: 
Harris Taylor C.
Chief Financial Officer
Myokardia, Inc. (MYOK) 06-Apr-20Market Option Sale 1,305$46.99$61,322.00(15%)
8.74K to 7.44K
07-Apr-20 5:42 PM
View: 
Harris Taylor C.
Chief Financial Officer
Myokardia, Inc. (MYOK) 04-Apr-20Option Exercise 3,750----75%
4.99K to 8.74K
06-Apr-20 4:06 PM
View: 
Gianakakos Anastasios
President and CEO
Director
Myokardia, Inc. (MYOK) 02-Apr-20Market Sale (Planned) 2,500$44.77$111,917.00(< 1%)
667.87K to 665.37K
(5%)
04-Mar-20 5:42 PM
View: 
Gianakakos Anastasios
President and CEO
Director
Myokardia, Inc. (MYOK) 02-Mar-20Private Sale (Planned) 5,000$64.45$322,246.00(< 1%)
672.87K to 667.87K
05-Feb-20 8:22 PM
View: 
Gianakakos Anastasios
President and CEO
Director
Myokardia, Inc. (MYOK) 03-Feb-20Private Sale (Planned) 5,000$69.36$346,821.00(< 1%)
677.85K to 672.85K
03-Feb-20 8:55 PM
View: 
Fairey William
See Remarks
Myokardia, Inc. (MYOK) 01-Feb-20Private Option Sale 2,899$68.04$197,248.00(36%)
8.13K to 5.23K
03-Feb-20 8:55 PM
View: 
Fairey William
See Remarks
Myokardia, Inc. (MYOK) 01-Feb-20Option Exercise 8,125----100%
0 to 8.13K
14-Jan-20 8:26 PM
View: 
Gianakakos Anastasios
President and CEO
Director
Myokardia, Inc. (MYOK) 14-Jan-20Private Sale (Planned) 5,000$75.39$376,964.00(< 1%)
682.85K to 677.85K
07-Jan-20 7:39 PM
View: 
McDowell Robert Scott
Chief Scientific Officer
Myokardia, Inc. (MYOK) 06-Jan-20Private Sale 2,650$68.45$181,395.00(33%)
8.03K to 5.38K
07-Jan-20 5:15 PM
View: 
Bauer Jake
Chief Business Officer
Myokardia, Inc. (MYOK) 06-Jan-20Private Option Sale 2,466$68.45$168,800.00(4%)
59.96K to 57.49K
07-Jan-20 7:39 PM
View: 
Harris Taylor C.
Chief Financial Officer
Myokardia, Inc. (MYOK) 06-Jan-20Private Sale 1,683$68.45$115,203.00(25%)
6.68K to 4.99K
07-Jan-20 7:39 PM
View: 
Gianakakos Anastasios
President and CEO
Director
Myokardia, Inc. (MYOK) 06-Jan-20Private Sale 12,687$68.45$868,439.00(2%)
695.54K to 682.85K
07-Jan-20 7:36 PM
View: 
Ladd Cynthia J
General Counsel
Myokardia, Inc. (MYOK) 06-Jan-20Private Sale 1,849$68.45$126,566.00(39%)
4.7K to 2.85K
03-Jan-20 8:18 PM
View: 
Gianakakos Anastasios
President and CEO
Director
Myokardia, Inc. (MYOK) 03-Jan-20Planned Private Option Sale 5,000$71.80$359,008.00(< 1%)
700.54K to 695.54K